3903782

PEER REVIEW IN THE AGE OF PREPRINTS AND PREDATORY JOURNALS | Poster Board #Sp1244

Date
May 9, 2023
Explore related products in the following collection:

Presenter

Speaker Image for Paul Moayyedi
McMaster University

Tracks

Related Products

Thumbnail for INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY
INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY
BACKGROUND: Irritable bowel syndrome (IBS) is a common disorder with complex pathophysiological mechanisms. Prior studies suggest that 25-50% of patients with diarrhea-predominant IBS (IBS-D) have evidence of bile acid (BA) diarrhea (BAD)…
Thumbnail for AGA The Future of Publishing: Insights from the Editors of Leading Medical Journals
AGA The Future of Publishing: Insights from the Editors of Leading Medical Journals
This session will feature the editors-in-chief of three leading medical journals, including Nature Medicine, Annals of Internal Medicine and Gastroenterology…
Thumbnail for ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY
ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY
INTRODUCTION: We aimed to investigate the relationship between consumption of ultra-processed foods (UPFs) and: 1) active symptomatic disease and 2) intestinal inflammation in a cohort of adults living with inflammatory bowel disease (IBD)…
Thumbnail for SERUM METABOLOMICS IDENTIFIES DYSREGULATED PATHWAYS AND POTENTIAL METABOLIC BIOMARKERS INVOLVED IN DEVELOPMENT OF CROHN’S DISEASE
SERUM METABOLOMICS IDENTIFIES DYSREGULATED PATHWAYS AND POTENTIAL METABOLIC BIOMARKERS INVOLVED IN DEVELOPMENT OF CROHN’S DISEASE
Aconitate decarboxylase 1 (ACOD1; also known as IRG-1) is the ubiquitous source of the metabolite itaconate, which dampens inflammasome activation by preventing HIF1α production of IL-1β and prevents TNF production through NRF2 activation…